Thus, we investigated the expression of SHP-1 and SHP-2 and of STAT1/3 to better understand their importance in relation with neuroinflammation in the pathology of HD, in the effort to find a possible therapeutic strategy to fight HD. The gene discussed is NR0B2; the disease is Huntington disease.